BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Deals

  Ventrus Biosciences, Inc. Announces Acquisition of Title to Hemorrhoids Product

  November 18, 2011

   · 

  1 min read
• BioMidwest

  Galena Biopharma Announces NeuVax(TM) Poster Presentations at the 34th Annual Cancer Therapy & Research Center (CTRC)-American Association for Cancer Research San Antonio Breast Cancer Symposium

  November 18, 2011

   · 

  1 min read
• Business

  Beijing Genomics Institute (BGI) Forms Children’s Disease Partnership With Children’s Hospital of Philadelphia

  November 18, 2011

   · 

  1 min read
• TomTec Imaging Systems GmbH Introduces Its Latest off-Line Processing Package at the Radiological Society of North America (RSNA) 2011

  November 18, 2011

   · 

  1 min read
• BioAlliance Pharma Ranked as France’s Fastest Growing Company in the 2011 Deloitte & Touche LLP (New York, New York)'s Technology Fast 50

  November 18, 2011

   · 

  1 min read
• Merz Pharmaceuticals, LLC Release: XEOMIN(R) (IncobotulinumtoxinA) Data to be Presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation

  November 18, 2011

   · 

  4 min read
• BioCapital

  Incyte Corporation to Present at the 23rd Annual Piper Jaffray Health Care Conference

  November 18, 2011

   · 

  1 min read
• Drug Development

  AlloCure Inc. Stem Cell Trial Provides Glimpse of Promising Treatment for Kidney Damage

  November 18, 2011

   · 

  1 min read
• Pharm Country

  NovoCure Ltd. Announces Data Presentations of NovoTTF-100A System(TM) at the 16th Annual Scientific Meeting of the Society for NeuroOncology

  November 18, 2011

   · 

  3 min read
• Pharm Country

  Bio-Reference Laboratories’ CEO Marc Grodman MD Speaks at Capitol Hill Consulting Group Policy Forum on the Contribution Genetic Tests Are Making to Cancer Care

  November 18, 2011

   · 

  1 min read